miR-134 overexpression inhibits signal transducer and activator of transcription 5-B (STAT5B), which in turn decreases heat shock protein 90 (HSP90) and BCL-2 levels, resulting in a decreased cell proliferation and increased CIS-induced apoptosis [68]. Here, BCL2 is linked to in situ carcinoma.